N@N

Market Maker Surveillance Report. PFE, TIBX, MO, HBAN, KNOL, ALXA, Bullishly Biased Price Friction For Wednesday, April 18th 2

April 18, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 3623 companies with "abnormal" market making, 2054 companies with positive Friction Factors and 3770 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bullish bias) in their stock prices. This means that there was more selling than buying in the stocks and their stock prices rose. PFIZER INC (NYSE:PFE), TIBCO Software Inc (NASDAQ:TIBX), ALTRIA GROUP INC (NYSE:MO), HUNTINGTON BANCSHARES INC (NASDAQ:HBAN), KNOLOGY, INC. (NASDAQ:KNOL), ALEXZA PHARMACEUTICALS INC (NASDAQ:ALXA). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  PFE     $0.140    0.63%     9,028,770    28.67%    10,655,802   33.84%    -1,627,032   Abnormal
  TIBX    $1.040    3.14%     4,890,489    36.19%    8,353,280    61.81%    -3,462,791   Abnormal
  MO      $0.080    0.25%     2,144,750    26.63%    3,431,520    42.60%    -1,286,770   Abnormal
  HBAN    $0.050    0.77%     13,075,454   47.58%    13,947,584   50.76%    -872,130     Abnormal
  KNOL    $1.350    7.50%     4,175,830    40.10%    6,236,678    59.89%    -2,060,848   Abnormal
  ALXA    $0.010    1.55%     546,314      27.62%    1,431,794    72.38%    -885,480     Abnormal

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above had more selling than buying on Wednesday and their stock prices rose. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows PFE with 1,627,032 greater shares of selling than buying (NetVol) and the stock price was up $0.14000. This means the Market Makers were trading the stock in a way inconsistent with normal supply and demand (Economics 101); more selling than buying should cause prices to drop.

PFIZER INC (NYSE:PFE) - Pfizer Inc., a biopharmaceutical company, offers prescription medicines for humans and animals worldwide. The company's Biopharmaceutical segments provides Lipitor for elevated LDL-cholesterol levels in the blood; Enbrel for rheumatoid arthritis, polyarticular juvenile rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, and ankylosing spondylitis; Lyrica for post-herpetic neuralgia, diabetic peripheral neuropathy, fibromyalgia, neuropathic pain, adjunctive treatment of epilepsy, and general anxiety disorder, as well as for use as an adjunctive therapy for adult patients with partial onset seizures; Prevnar/Prevenar for invasive pneumococcal disease; Celebrex for osteoarthritis and rheumatoid arthritis, and acute pain; Viagra for erectile dysfunction; Xalabrands for reducing elevated eye pressure; Effexor XR for depressive, generalized anxiety, social anxiety, and panic disorders; and Norvasc for hypertension. It also offers Zyvox for gram-positive pathogens; Premarin for menopausal symptoms; Sutent for renal cell carcinoma; Geodon/Zeldox for schizophrenia; Detrol/Detrol LA for overactive bladder; Zosyn/Tazocin, an intravenous antibiotic; Genotropin for growth hormone deficiency; Vfend, an antifungal agent; and Protonix for gastroesophageal reflux disease; Chantix/Champix for aid smoking cessation; BeneFIX, ReFacto AF, and Xyntha for lifelong bleeding disorder; Caduet for cardiovascular events; Revatio for pulmonary arterial hypertension; Pristiq for depressive disorder; Aricept for Alzheimers disease; and Spiriva for breathing problems. The companys Diversified segment offers animal health products, such as vaccines, anti-infectives, anti-inflammatories, antiemetics, and parasiticides; consumer healthcare products, such as dietary supplements, pain management, respiratory, and personal care; nutrition products; and gelatin, liquid, softgel, non-animal, and fish gelatin capsules. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

TIBCO Software Inc (NASDAQ:TIBX) - TIBCO Software Inc. provides middleware and infrastructure software worldwide. It offers its products in the areas of service-oriented architecture (SOA), business optimization, and business process management (BPM). The companys SOA product line turns information and functions into discrete and reusable components that can be invoked from across the business and aggregated with other such services to create infrastructure applications; and delivers capabilities in the areas of service mediation, orchestration and communication, and the development of Internet applications. Its business optimization product portfolio assists organizations to convert and analyze data to create information and deliver it to employees, customers, and partners. The companys BPM product line assists organizations to coordinate the human and electronic resources inside a business, as well as its network of customers and partners. It also provides professional services that include a range of consulting services, such as systems planning and design, installation, and systems integration, as well as offers maintenance and support, and training services. The company serves various industries, such as energy, financial services, government, insurance, life sciences, logistics, manufacturing, retail, telecommunications, and transportation. It sells its products through a direct sales force, and through alliances with software vendors and systems integrators. TIBCO Software Inc. was incorporated in 1996 and is based in Palo Alto, California.

ALTRIA GROUP INC (NYSE:MO) - Altria Group, Inc., through its subsidiaries, engages in the manufacture and sale of cigarettes, wine, and other tobacco products in the United States and internationally. It primarily offers cigarettes under the Marlboro, Virginia Slims, and Parliament brands; smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as Marlboro snus; and machine-made large cigars and pipe tobacco. The company also maintains a portfolio of leveraged and direct finance leases principally in transportation, including aircraft, as well as power generation and manufacturing equipment, and facilities. It serves wholesalers, including distributors; large retail organizations, such as chain stores; and the armed services. The company was founded in 1919 and is headquartered in Richmond, Virginia.

HUNTINGTON BANCSHARES INC (NASDAQ:HBAN) - Huntington Bancshares Incorporated operates as the holding company for The Huntington National Bank that provides commercial and consumer banking services. It offers deposit products, including checking accounts, savings accounts, interest bearing and non-interest bearing demand deposits, time deposits, money market deposits, and brokered deposits and negotiable certificate of deposits. The companys loan portfolio comprises home equity loans and lines of credit, first mortgage loans, direct installment loans, small business loans, automobile loans and leases, residential mortgage loans, commercial and industrial loans and leases, and commercial real estate loans. It also provides retail and commercial insurance agency services; and an array of insurance products, including individual life insurance products, such as basic term-life insurance, estate planning, group life and health insurance, property and casualty insurance, mortgage title insurance, and reinsurance for payment protection products. In addition, the company offers trust, asset management, investment advisory, brokerage, and private banking products and services; and investment banking, sales and trading of securities, mezzanine capital financing, and interest rate risk management products for corporate and institutional customers. Further, Huntington Bancshares provides mortgage banking, equipment leasing, and other financial products and services; and Internet banking and telephone banking services. As of December 31, 2009, the company operated 340 banking offices in Ohio, 115 in Michigan, 56 in Pennsylvania, 50 in Indiana, 28 in West Virginia, and 13 banking offices in Kentucky, as well as 9 private banking offices in Florida, 1 foreign office in the Cayman Islands, and 1 foreign office in Hong Kong. It also operated approximately 1,300 automated teller machines. The company was founded in 1866 and is headquartered in Columbus, Ohio.

KNOLOGY, INC. (NASDAQ:KNOL) - Knology, Inc. provides video, voice, data, and advanced communications services to residential and business customers in the southeastern and midwestern United States. It offers approximately 200 channels of digital cable TV, local, and long distance digital telephone service with enhanced voice messaging features, and high-speed Internet access, which enables consumers to download video, audio, and graphic files using a cable modem. The companys video services comprise analog cable service, which include a package of basic programming comprising local broadcast television and local community programming, including public, educational, and government access channels; and the expanded basic level of programming, which include satellite-delivered or non-broadcast channels, such as ESPN, MTV, USA, CNN, The Discovery Channel, Nickelodeon, and home shopping networks. Its video services also include digital cable service, HD channels, and premiums, which include channels of digital programming, basic cable service, and music channels, as well as high definition TV, digital video recorder, video-on-demand, and subscription video-on-demand; and premium channels, such as HBO, Showtime, Starz, Encore, and Cinemax, which provide commercial-free movies, and sports and other special event entertainment programming. The companys voice services consist of local and long-distance telephone services comprising local area calling plans, flat-rate local and long-distance plans, and measured and fixed rate toll packages based on usage. It also provides business voice and data, broadband carrier, and high-speed Internet access services. The company provides its services over its wholly owned 750 MHz interactive broadband network. As of December 31, 2009, its network passed approximately 932,834 homes and had approximately 693,871 total connections. The company was founded in 1995 and is based in West Point, Georgia.

ALEXZA PHARMACEUTICALS INC (NASDAQ:ALXA) - Alexza Pharmaceuticals, Inc., a development stage company, focuses on the research, development, and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product candidates are based on a proprietary technology, the Staccato system that vaporizes an excipient-free drug to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery. The companys clinical-stage product candidates comprise AZ-004 (staccato loxapine), which is licensed to Biovail Laboratories International SRL for the acute treatment of agitation in patients with schizophrenia or bipolar disorder; AZ-007 (staccato zaleplon), which completed phase I status for the treatment of insomnia; and AZ-001 (staccato prochlorperazine) and AZ-104 (staccato loxapine, low-dose), phase II product candidates for the treatment of migraine headache. It also develops AZ-002 (Staccato alprazolam), which completed a phase 1 clinical trial in healthy subjects and a phase 2a proof-of-concept clinical trial in panic disorder patients for the treatment of panic attacks; and AZ-003 (Staccato fentanyl) that completed phase 1 clinical trial for the treatment of patients with acute pain, including patients with breakthrough cancer pain and postoperative patients with acute pain episodes. The company was formerly known as Alexza Molecular Delivery Corporation and changed its name to Alexza Pharmaceuticals, Inc. in July 2005. Alexza Pharmaceuticals, Inc. was founded in 2000 and is based in Mountain View, California.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net

Contributing Sources

---